Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Prescription Drugs Overall Market Size
2.1 Global Anti-Obesity Prescription Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Obesity Prescription Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Obesity Prescription Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Obesity Prescription Drugs Players in Global Market
3.2 Top Global Anti-Obesity Prescription Drugs Companies Ranked by Revenue
3.3 Global Anti-Obesity Prescription Drugs Revenue by Companies
3.4 Global Anti-Obesity Prescription Drugs Sales by Companies
3.5 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Obesity Prescription Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Obesity Prescription Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Prescription Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Prescription Drugs Market Size Markets, 2022 & 2029
4.1.2 Pediatric
4.1.3 Adult
4.2 By Type - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Obesity Prescription Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Prescription Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.1.4 E-commerce
5.2 By Application - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Obesity Prescription Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Obesity Prescription Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Obesity Prescription Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Prescription Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Obesity Prescription Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Obesity Prescription Drugs Sales, 2018-2029
6.4.3 US Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Obesity Prescription Drugs Sales, 2018-2029
6.5.3 Germany Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.4 France Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Obesity Prescription Drugs Sales, 2018-2029
6.6.3 China Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.6.7 India Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Obesity Prescription Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Obesity Prescription Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Obesity Prescription Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 F Hoffmann La Roche Ltd
7.1.1 F Hoffmann La Roche Ltd Company Summary
7.1.2 F Hoffmann La Roche Ltd Business Overview
7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Major Product Offerings
7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.1.5 F Hoffmann La Roche Ltd Key News & Latest Developments
7.2 Orexigen Therapeutics
7.2.1 Orexigen Therapeutics Company Summary
7.2.2 Orexigen Therapeutics Business Overview
7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Major Product Offerings
7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Orexigen Therapeutics Key News & Latest Developments
7.3 Novo Nordisk A/s
7.3.1 Novo Nordisk A/s Company Summary
7.3.2 Novo Nordisk A/s Business Overview
7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Major Product Offerings
7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Novo Nordisk A/s Key News & Latest Developments
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Company Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Arena Pharmaceuticals Key News & Latest Developments
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Company Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Major Product Offerings
7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Glaxosmithkline Key News & Latest Developments
7.6 Vivus
7.6.1 Vivus Company Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Anti-Obesity Prescription Drugs Major Product Offerings
7.6.4 Vivus Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Vivus Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Major Product Offerings
7.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Alizyme
7.8.1 Alizyme Company Summary
7.8.2 Alizyme Business Overview
7.8.3 Alizyme Anti-Obesity Prescription Drugs Major Product Offerings
7.8.4 Alizyme Anti-Obesity Prescription Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Alizyme Key News & Latest Developments
8 Global Anti-Obesity Prescription Drugs Production Capacity, Analysis
8.1 Global Anti-Obesity Prescription Drugs Production Capacity, 2018-2029
8.2 Anti-Obesity Prescription Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Prescription Drugs Supply Chain Analysis
10.1 Anti-Obesity Prescription Drugs Industry Value Chain
10.2 Anti-Obesity Prescription Drugs Upstream Market
10.3 Anti-Obesity Prescription Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer